064400:KRXLG CNS Analysis
Data as of 2026-07-28 - not real-time
₩61,800.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
LG CNS is trading well below its 30‑day DCF fair value, offering a sizable margin of safety while delivering a respectable 2.76% dividend yield. The stock’s forward P/E of roughly eleven contrasts sharply with the industry average of over thirty, underscoring a clear undervaluation. Technical signals are turning positive: the 14‑day RSI sits in the low‑40s, suggesting oversold conditions, and the MACD histogram has flipped to bullish territory. Volume has been tapering, yet the market cap remains robust and daily liquidity is adequate. The price is hovering just above a key support zone near 60,500 KRW, with a clear upside path toward the 82,300 KRW resistance level. Combined with a strong cash position and manageable debt, the fundamentals support a constructive outlook.
Looking ahead, the company’s revenue is growing at a healthy double‑digit pace, driven by expanding cloud, AI, and digital transformation services. Operating margins are modest but stable, and free cash flow generation comfortably covers dividend payouts, indicating sustainability. While the beta of 1.66 and 30‑day volatility nearing 70% flag heightened market sensitivity, the long‑term secular demand for IT services in Korea and abroad provides a solid growth backdrop. Investors should weigh the attractive valuation and dividend yield against the elevated price swings, positioning LG CNS as a compelling candidate for value‑oriented, dividend‑seeking portfolios.
Looking ahead, the company’s revenue is growing at a healthy double‑digit pace, driven by expanding cloud, AI, and digital transformation services. Operating margins are modest but stable, and free cash flow generation comfortably covers dividend payouts, indicating sustainability. While the beta of 1.66 and 30‑day volatility nearing 70% flag heightened market sensitivity, the long‑term secular demand for IT services in Korea and abroad provides a solid growth backdrop. Investors should weigh the attractive valuation and dividend yield against the elevated price swings, positioning LG CNS as a compelling candidate for value‑oriented, dividend‑seeking portfolios.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicating oversold conditions
- Bullish MACD crossover
- Price near strong support with upside to resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Attractive dividend yield with sustainable payout
- Robust cash flow covering debt and dividends
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Secular growth in cloud, AI, and digital transformation services
- Solid balance sheet with ample cash reserves
- Undervalued relative to peers despite higher beta
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin7.41%
P/E Ratio11.1
ROE16.64%
ROA7.46%
Debt/Equity18.49
Op. Cash Flow₩618.2B
Free Cash Flow₩425.3B
Industry P/E32.6
Technical Analysis
TrendNeutral
RSI38.1
Support₩60,500.00
Resistance₩82,300.00
MA 20₩69,325.00
MA 50₩83,804.00
MA 200₩69,423.50
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Fair Value₩94,016.06
Target Price₩102,923.08
Upside/Downside66.54%
GradeUndervalued
TypeBlend
Dividend Yield2.76%
Risk Assessment
Beta1.67
Volatility69.70%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.